PRTX-100: Interim Phase Ib data

Interim data from 41 patients with active RA in the first 4 cohorts of the double-blind, placebo-controlled, U.S. Phase Ib SPARTA (PRTX-100-104) trial showed that once-weekly 1.5, 3, 6 and 12 ug/kg do...